NeOnc Technologies Holdings is trading 8.07% higher at $2.97 in pre-market, with no confirmed catalyst directly explaining the move.

  • Coverage highlighted CEO Amir Heshmatpour’s planned Abu Dhabi Future Health Summit appearance and UAE clinical-development efforts, but did not link them to the rise.
  • Ali Alabedin’s board appointment was announced October 14, not as a new October 16 announcement.
  • Supplied broader market indicators were mixed and showed no clear same-direction move explaining the gain.